$阿玛琳(AMRN)$
SA的文章，每次阿玛琳取得阶段性成果时，安慰剂都被拿出来说事儿。

Amarin's Mineral Menace

Nov 15, 2018 • NJ Biotech Expert

Dr. Chowdhury with the FDA determined that mineral oil was an acceptable placebo during the original drafting of the NDA for Vascepa in 2011.

This same exact issue has been brought up by critics with the Marine Trial, the Anchor Trial, and now the REDUCE-IT Trial.

Each time it is brought up, the market overreacts and sells for a short period of time, followed by a significant increase in stock price.